SEC Form 4 · accession 0001225208-17-014366
CLOROX CO /DE/ · CLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon M Balousek
Officer — SVP - GM, Specialty Div
Period of report
Aug 23, 2017
Accepted (ET)
Aug 25, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000021076
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 23, 2017 | M | 5,387 | $72.11 | A | 20,614 | D | |
| Common Stock | Aug 23, 2017 | M | 1,707 | $74.09 | A | 22,321 | D | |
| Common StockF1 | Aug 23, 2017 | S | 9,223 | $138.8727 | D | 13,098 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $74.09 | Aug 23, 2017 | M | 1,707 | D | Jan 2, 2014 | Jan 2, 2023 | Common Stock | 1,707 | 0 | D |
| Stock Option (Right to Buy) | $72.11 | Aug 23, 2017 | M | 5,387 | D | Sep 11, 2013 | Sep 11, 2022 | Common Stock | 5,387 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $138.767 to $139.045. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.